• Solid 1HY26 results with 30% growth in underlying profit
• Signed 7 new deals worth over $280M and renewed $20M contract
• Investment in 4D Medical valued at nearly $150M unrealized gain
• AI not seen as a disruptor, company well-positioned with proprietary tech

In the interview, Pro Medicus CEO Dr. Sam Hupert discusses the company's solid 1HY26 results, noting that excluding a one-off contribution from the 4D Medical investment, the company grew its underlying profit after tax by approximately 30%. All other financial metrics, including retained earnings and EBIT margins, also increased period-on-period. On the sales side, the company signed 7 new deals with a total minimum value of over $280 million, as well as completing 6 implementations in the half. Dr. Hupert highlights that the company sold in 6 months what it used to sell in a year before the Trinity deal in 2025, and its total minimum contracted volume for the next 5 years has climbed to over $1 billion for the first time. Regarding the 4D Medical investment, Dr. Hupert notes that it has resulted in an unrealized gain of just under $150 million, though the ultimate value will be determined by the share price in 2027. When asked about the impact of AI, Dr. Hupert dismisses concerns, stating that the company's proprietary technology and implementation capabilities make it well-positioned to withstand potential disruption. He also discusses the company's cloud-based implementation approach, which has enabled it to complete large-scale go-lives more efficiently. Finally, Dr. Hupert comments on the company's strong pipeline, noting that it spans the full range of market segments and that the company's attendance at RSNA generated many new leads.

Pro Medicus expects to continue delivering higher absolute growth to maintain its 30%+ profit growth rate, driven by the implementation of recent sales and increased usage and take-up of additional products by existing customers. The company plans to continue paying out roughly 50% of profits as dividends.

Pro Medicus remains confident in its ability to sustain growth going forward, driven by the implementation of recent sales, increased usage and take-up of additional products by existing customers, and its strong pipeline spanning the full range of market segments.